June 1997
Volume 38, Issue 7
Free
Articles  |   June 1997
MK-801 has neuroprotective and antiproliferative effects in retinal laser injury.
Author Affiliations
  • Y Solberg
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel-Aviv University, Israel.
  • M Rosner
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel-Aviv University, Israel.
  • J Turetz
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel-Aviv University, Israel.
  • M Belkin
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel-Aviv University, Israel.
Investigative Ophthalmology & Visual Science June 1997, Vol.38, 1380-1389. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y Solberg, M Rosner, J Turetz, M Belkin; MK-801 has neuroprotective and antiproliferative effects in retinal laser injury.. Invest. Ophthalmol. Vis. Sci. 1997;38(7):1380-1389.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: Treatment of the retina by laser photocoagulation often is complicated by an immediate side effect of visual impairment, caused by unavoidable, laser-induced destruction of healthy tissue adjacent to the lesion. A neuroprotective therapy that salvages this healthy tissue might enhance the benefit obtained from the treatment. This study was proposed to determine whether glutamate-receptor blockers can provide adjuvant neuroprotection during laser photocoagulation. The effect of MK-801, an NMDA-receptor antagonist, on laser-induced retinal injury was examined, in a rat model. METHODS: Argon laser lesions were created in the retinas of 36 DA rats, and were followed immediately by intraperitoneal injections of MK-801 (2 mg/kg) or saline. The animals were killed after 3, 20, or 60 days and the retinal lesions were evaluated histologically and morphometrically. RESULTS: Photoreceptor-cell loss was significantly less in MK-801-treated rats than in control animals. The proliferative membrane composed of retinal pigment epithelial cells and neovascular blood vessels, which was seen at the base of the lesion in control group retinas, was smaller in the MK-801-treated retinas. In rats treated with a higher dose of MK-801, the lesions showed almost no proliferative reaction. CONCLUSIONS: A potent noncompetitive NMDA-receptor blocker, MK-801 exhibits neuroprotective and antiproliferative properties in the retina. Glutamate-receptor blockers should be investigated further as potential adjuvant therapy in retinal photocoagulation treatments.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×